Statera Biopharma, Inc. (STAB)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jan 21, 2025, 3:00 PM EST
Statera Biopharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
Period Ending | Sep '22 Sep 30, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
| Cash & Equivalents | 0.51 | 1.84 | 0.59 | 0 | 0.01 |
| Short-Term Investments | - | 0.13 | - | - | - |
| Cash & Short-Term Investments | 0.51 | 1.98 | 0.59 | 0 | 0.01 |
| Cash Growth | -94.64% | 233.29% | 35892.06% | -85.03% | - |
| Accounts Receivable | 0.36 | 0.35 | - | - | - |
| Other Receivables | - | - | 0.33 | - | - |
| Receivables | 0.36 | 0.35 | 0.33 | - | - |
| Prepaid Expenses | 0.1 | 0.98 | - | - | - |
| Other Current Assets | 0.26 | 0.85 | 0 | - | 0.42 |
| Total Current Assets | 1.22 | 4.16 | 0.93 | 0 | 0.43 |
| Property, Plant & Equipment | 1.02 | 1.17 | 0.11 | - | - |
| Goodwill | 9.27 | 9.27 | - | - | - |
| Other Intangible Assets | 1.24 | 1.58 | - | - | - |
| Other Long-Term Assets | - | 5 | - | - | - |
| Total Assets | 12.75 | 21.17 | 1.04 | 0 | 0.43 |
| Accounts Payable | 8.13 | 3.96 | 1.13 | 2.41 | 1.71 |
| Accrued Expenses | 6.31 | 1.75 | 1.55 | - | - |
| Short-Term Debt | 6.4 | 4.58 | 1.9 | 1.8 | 1.57 |
| Current Portion of Leases | 0.32 | 0.25 | 0.03 | - | - |
| Current Unearned Revenue | 0.39 | 0.37 | - | - | - |
| Other Current Liabilities | 0.68 | 0.33 | - | - | - |
| Total Current Liabilities | 22.23 | 11.25 | 4.62 | 4.21 | 3.29 |
| Long-Term Debt | - | 10.63 | - | - | - |
| Long-Term Leases | 0.69 | 0.81 | 0.07 | - | - |
| Total Liabilities | 22.92 | 22.68 | 4.69 | 4.21 | 3.29 |
| Common Stock | 0.25 | 0.18 | 0.16 | 0.02 | 0.02 |
| Additional Paid-In Capital | 133.53 | 127.74 | 23.95 | 11.31 | 9.43 |
| Retained Earnings | -144.08 | -129.48 | -27.76 | -15.54 | -12.31 |
| Comprehensive Income & Other | 0.05 | -0.01 | - | - | - |
| Total Common Equity | -10.24 | -1.57 | -3.66 | -4.21 | -2.86 |
| Minority Interest | 0.07 | 0.06 | - | - | - |
| Shareholders' Equity | -10.17 | -1.51 | -3.66 | -4.21 | -2.86 |
| Total Liabilities & Equity | 12.75 | 21.17 | 1.04 | 0 | 0.43 |
| Total Debt | 7.41 | 16.26 | 2 | 1.8 | 1.57 |
| Net Cash (Debt) | -6.9 | -14.28 | -1.41 | -1.8 | -1.56 |
| Net Cash Per Share | -0.14 | -0.41 | -0.19 | -0.09 | -0.09 |
| Filing Date Shares Outstanding | 54.66 | 51.14 | 24.34 | 20.35 | 17.1 |
| Total Common Shares Outstanding | 50.74 | 35.48 | 24.34 | 20.35 | 17.1 |
| Working Capital | -21.01 | -7.09 | -3.7 | -4.21 | -2.86 |
| Book Value Per Share | -0.20 | -0.04 | -0.15 | -0.21 | -0.17 |
| Tangible Book Value | -20.75 | -12.42 | -3.66 | -4.21 | -2.86 |
| Tangible Book Value Per Share | -0.41 | -0.35 | -0.15 | -0.21 | -0.17 |
| Machinery | - | 0.23 | 0.01 | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.